Bentham Science Logo

Letters in Drug Design & Discovery

Volume 16, 12 Issues, 2019
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

Ranking and Category

  • 57th of 61 in

    Chemistry, Medicinal

Order Your Article Before Print

Contents

Letters in Drug Design & Discovery, Volume 2 - Number 3





A Facile Synthesis of C2-Substituted Pyrrolo[2,3-f]quinolines with Cytotoxic Activity

, 2(3): 189 - 192

Andrew Tsotinis, Margarita Vlachou, Spyridon Zouroudis, Andras Jeney, Ferenc Timar, David E. Thurston and Christos Roussakis


DOI: 10.2174/1570180053765075




Preliminary In vitro Results Indicating Tartronic Acids as Aspartic Acid Mimetics in Vitronectin Receptor Antagonists: Evidence for Increased Hydroxyapatite Affinity

, 2(3): 201 - 204

Diane B. Hauze, Kenneth L. Kees, Charles W. Mann, Horace Fletcher III, Richard Murrills, Jeanne Matteo, Frederick Bex, Bheem Bhat and Valerie Coleburn


DOI: 10.2174/1570180053765110



Pyrazinobenzodiazepines as Potent Nonpeptide Vasopressin Receptor Antagonists

, 2(3): 219 - 223

Jay M. Matthews, Dennis J. Hlasta, Patricia Andrade-Gordon, Keith T. Demarest, Eric Ericson, Joseph W. Gunnet, William Hageman, Richard Look, John B. Moore and Bruce E. Maryanoff


DOI: 10.2174/1570180053765183










Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
Czech Republic

Biography View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Advertisement

Special New Year Discount

Related Journals

Related eBooks

eBooks Catalog